[1]熊义博.中药丹参治疗骨质疏松的作用及其机制[J].医学信息,2020,33(09):44-46,56.[doi:10.3969/j.issn.1006-1959.2020.09.014]
　XIONG Yi-bo.Study on the Treatment of Osteoporosis with Salvia Miltiorrhiza[J].Medical Information,2020,33(09):44-46,56.[doi:10.3969/j.issn.1006-1959.2020.09.014]
点击复制

中药丹参治疗骨质疏松的作用及其机制()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
33卷
期数:
2020年09期
页码:
44-46,56
栏目:
综述
出版日期:
2020-05-01

文章信息/Info

Title:
Study on the Treatment of Osteoporosis with Salvia Miltiorrhiza
文章编号:
1006-1959（2020）09-0044-04
作者:
熊义博
（解放军联勤保障部队第九二四医院，广西 桂林 541001）
Author(s):
XIONG Yi-bo
(The 924th Hospital of the Joint Logistics Support Force of the PLA,Guilin 541001,Guangxi,China)
关键词:
丹参; 骨质疏松; 作用机制
Keywords:
Salvia; Osteoporosis; Mechanism of action
分类号:
R285.5
DOI:
10.3969/j.issn.1006-1959.2020.09.014
文献标志码:
A
摘要:
丹参为唇形科植物丹参（Salvia miltiorrhiza Bge.）的干燥根及根茎，广泛用于治疗心脑血管疾病，近年来研究发现丹参可通过RANK/RANKL/OPG信号通路、FoxO/Wnt信号通路、作为组织蛋白酶K抑制剂等作用，促进骨骼的生长与愈合，预防个体骨骼的损伤和坏死，有效降低老年人或绝经期妇女骨吸收生物指标，达到治疗骨质疏松的作用。本文现就丹参及其活性成分、对骨质疏松的治疗作用及其机制研究进行综述。
Abstract:
Salvia miltiorrhiza is the dried root and rhizome of(Salvia miltiorrhiza Bge.),which is widely used in the treatment of cardiovascular and cerebrovascular diseases. In recent years, it has been found that salvia miltiorrhiza can pass the RANK/RANKL/OPG signaling pathway, FoxO/Wnt signaling pathway As a cathepsin K inhibitor, it can promote the growth and healing of bones, prevent the damage and necrosis of individual bones, effectively reduce the biological indicators of bone resorption in elderly or menopausal women, and achieve the effect of treating osteoporosis. This article now reviews the research on salvia miltiorrhiza and its active ingredients, its therapeutic effect on osteoporosis and its mechanism.

参考文献/References:

[1]Lee WC,Guntur AR,Long F,et al.Energy Metabolism of the Osteoblast:Implications for Osteoporosis[J].Endocrine Reviews,2017,38(3):255-266.[2]Thiel A,Reumann MK,Boskey A,et al.Osteoblast migration in vertebrate bone [J].Biol Rev Camb Philos Soc,2018,93(1):350-363.[3]Szekanecz Z,Raterman HG,Petho Z,et al.Common mechanisms and holistic care in atheroscl erosis and osteoporosis[J].Arthritis Res Ther,2019,21(1):15.[4]Hongo T,Kotake K,Muramatsu H,et al.Loss of bone mineral density following sepsis usingHounsfifield units by computed tomograph[J].Acute Med Surg,2019,6(2):173-179.[5]Mukherjee K,Chattopadhyayn.Pharmacological inhibition of cathepsin K:A promising novel approach for postmenopausal osteoporosis therapy[J].Biochem Pharmacol,2016(117):10-19.[6]陈旭青,陈醒,吴苏亚,等.超高效液相色谱法对丹参不同部位化学成分的研究[J].安徽医药,2018,22(11):2096-2099.[7]张晓燕,刘运新,吴铁.丹参素对牙槽骨成骨细胞细胞核因子-kB受体活化因子配体/骨保护素表达的影响研究[J].口腔生物学与口腔材料学研究,2019,35(9):894-897.[8]屈涛,甄平,杨成伟,等.丹参素对去势大鼠骨质量的影响[J].浙江大学学报(医学版),2016,45(6):587-591.[9]Liu YY,Shen HL.Salvianolic Acid B Administration Attenuate Bone Loss in Ovariectomy Induced Rat Model[J].International Journal of Pharmacology,2018,14(6):866-872.[10]Zhang JM,Li J,Liu EW,et al.Danshen enhanced the estrogenic effects of Qing E formula in ovariectomized rats[J].BMC Complementary and Alternative Medicine,2016(16):181.[11]杨芳芳.丹参酮ⅡA抗骨质疏松活性及其提取分离工艺研究[D].甘肃中医药大学,2018.[12]杨亚军.丹参素通过调控FoxO/Wnt通路抑制氧化应激介导骨质疏松的作用及机制研究[D].南方医科大学,2014.[13]王秉义,潘剑.丹参素拮抗氧化应激所致骨质疏松并通过PI3k/Akt通路减少骨细胞的凋亡[J].中国骨质疏松杂志,2017:23(1):1-11.[14]林民贵,肖彦燊.丹参酚酸抗类风湿性关节炎致骨质疏松的实验研究[J].中国实用医药,2014,9(21):16-17.[15]雒志恒,祁珊珊,冯自立,等.葛根素和丹参酮ⅡA对维甲酸诱导骨质疏松大鼠生殖系统的修复作用[J].中国骨质疏松杂志,2017,23(6):800-806.[16]曹子君,王亚兰,陈妮妮,等.精氨酸加压素联合丹参素对骨质疏松患者成骨细胞凋亡及增殖的影响[J].川北医学院学报,2019,34(4):354-357.[17]Kwak HB,Yang D,Ha H,et al.TanshinoneⅡA inhibits osteoclast differentiation through down-regulation of c-Fos and NFATc1[J].Experimental&Molecular Medicine,2006,38(3):256-264.[18]Wang J,Wu X,Duan Y.Magnesium Lithospermate B Protects against Lipopolysaccharide-Induced Bone Loss by Inhibiting RANKL/RANK Pathway[J].Frontiers in Pharmacology,2018(9):64.[19]Xu D,Xu L,Zhou C,et al.Salvianolic acid B promotes osteogenesis of human mesenchymal stem cells through activating ERK signaling pathway[J].International Journal of Biochemistry and Cell Biology,2014(51):1-9.[20]Yang YJ,Zhu Z,Wang DT,et al.Tanshinol alleviates impaired bone formation by inhibiting adipogenesis via KLF15/PPARγ2 signaling in GIO rats [J].Acta Pharmacologica Sinica, 2018,39(4):633-641.[21]Panwar P,Law S,Jamroz A,et al.Tanshinones that selectively block the collagenase activity of cathepsin K provide a novel class of ectosteric antiresorptive agents for bone[J].British Journal of Pharmacology,2018,175(6):902-923.[22]Xu D,Xu L,Zhou C,et al.Salvianolic acid B promotes osteogenesis of human mesenchymal stem cells through activating ERK signaling pathway[J].The International Journal of Biochemistry&Cell Biology,2014(51):1-9.[23]董冰子,孙晓方.骨质疏松症治疗新进展:从分子机制到药物靶点[J].中华骨质疏松和骨矿盐疾病杂志,2018,11(6):620-627.

相似文献/References:

[1]王 忻,赵 毅,朱 悦,等.甲状旁腺激素应用于大鼠脊髓损伤后防治骨质疏松的效果分析[J].医学信息,2018,31(02):54.[doi:10.3969/j.issn.1006-1959.2018.02.019]
　WANG Xin,ZHAO Yi,ZHU Yue,et al.Effect of Parathyroid Hormone on Prevention and Treatment of Osteoporosis after Spinal Cord Injury in Rats[J].Medical Information,2018,31(09):54.[doi:10.3969/j.issn.1006-1959.2018.02.019]
[2]吴玲,李玉兰.个性化心理护理干预应用于骨质疏松的临床效果观察[J].医学信息,2018,31(01):158.[doi:10.3969/j.issn.1006-1959.2018.01.062]
　WU Ling,LI Yu-lan.The Clinical Effect of Personalized Psychological Nursing Intervention on Osteoporosis[J].Medical Information,2018,31(09):158.[doi:10.3969/j.issn.1006-1959.2018.01.062]
[3]刘小花.经皮穿刺椎体成形术治疗老年性骨质疏松性 椎体压缩骨折的疗效分析[J].医学信息,2018,31(05):186.[doi:10.3969/j.issn.1006-1959.2018.05.070]
　LIU Xiao-hua.The Effect of Percutaneous Vertebroplasty in the Treatment of Senile Osteoporotic Vertebral Compression Fracture[J].Medical Information,2018,31(09):186.[doi:10.3969/j.issn.1006-1959.2018.05.070]
[4]杨可佳,孙春华,洪全明,等.经皮椎体成形术治疗骨质疏松性压缩性椎体骨折的疗效观察[J].医学信息,2018,31(17):98.[doi:10.3969/j.issn.1006-1959.2018.17.030]
　YANG Ke-jia,SUN Chun-hua,HONG Quan-ming,et al.Therapeutic Effect of Percutaneous Vertebroplasty for treatment of Osteoporotic Vertebral Compression Fracture[J].Medical Information,2018,31(09):98.[doi:10.3969/j.issn.1006-1959.2018.17.030]
[5]蒋俊良.老年股骨转子间骨折的手术治疗方法[J].医学信息,2018,31(23):58.[doi:10.3969/j.issn.1006-1959.2018.23.017]
　JIANG Jun-liang.Research Progress of Intertrochanteric Fractures of Femurin the Elderly[J].Medical Information,2018,31(09):58.[doi:10.3969/j.issn.1006-1959.2018.23.017]
[6]张 强,杨 帆,陈 康,等.椎体成形术中明胶海绵填塞治疗椎体前壁破损的 OVCFs的临床疗效观察[J].医学信息,2019,32(11):85.[doi:10.3969/j.issn.1006-1959.2019.11.023]
　ZHANG Qiang,YANG Fan,CHEN Kang,et al.Clinical Observation of OVCFs in the Treatment of Anterior Wall Fracture of Vertebral Body with Gelatin Sponge During Vertebroplasty[J].Medical Information,2019,32(09):85.[doi:10.3969/j.issn.1006-1959.2019.11.023]
[7]庞 渊,张 庆,阿伍提·艾克木,等.经皮椎体成形术治疗骨质疏松性椎体压缩性骨折的 疗效分析[J].医学信息,2019,32(11):116.[doi:10.3969/j.issn.1006-1959.2019.11.033]
　PANG Yuan,ZHANG Qing,Awti Aikemu,et al.Therapeutic Effect of Percutaneous Vertebroplasty in the Treatment of Osteoporotic Vertebral Compression Fractures[J].Medical Information,2019,32(09):116.[doi:10.3969/j.issn.1006-1959.2019.11.033]
[8]罗巧彦,凌止发,严宗逊,等.中老年女性骨代谢指标与骨质疏松的相关性研究[J].医学信息,2019,32(17):68.[doi:10.3969/j.issn.1006-1959.2019.17.021]
　LUO Qiao-yan,LING Zhi-fa,YAN Zong-xun,et al.Correlation between Bone Metabolic Markers and Osteoporosis in Middle-aged and Elderly Women[J].Medical Information,2019,32(09):68.[doi:10.3969/j.issn.1006-1959.2019.17.021]
[9]熊义博,刘学员,邓泽熙,等.老年人骨质疏松与动脉硬化的关系[J].医学信息,2019,32(19):106.[doi:10.3969/j.issn.1006-1959.2019.19.033]
　XIONG Yi-bo,LIU Xue-yuan,DENG Ze-xi,et al.Relationship Between Osteoporosis and Arteriosclerosis in the Elderly[J].Medical Information,2019,32(09):106.[doi:10.3969/j.issn.1006-1959.2019.19.033]
[10]常 双,殷晓明,殷兰芳,等.FRAX联合血清学指标评估老年T2DM患者骨质疏松风险的研究[J].医学信息,2022,35(16):76.[doi:10.3969/j.issn.1006-1959.2022.16.017]
　CHANG Shuang,YIN Xiao-ming,YIN Lan-fang,et al.Evaluation of Osteoporosis Risk in Elderly Patients with T2DM by FRAX Combined with Serological Markers[J].Medical Information,2022,35(09):76.[doi:10.3969/j.issn.1006-1959.2022.16.017]

更新日期/Last Update: 2020-05-01